Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Arch. endocrinol. metab. (Online) ; 60(3): 252-263, tab, graf
Article Dans Anglais | LILACS | ID: lil-785225

Résumé

ABSTRACT The proper dietary calcium intake and calcium supplementation, when indicated, are important factors in the acquisition of peak bone mass during youth and in the prevention of fractures in old age. In addition to its deposition in bone, calcium confers an increase in its resistance and exhibits important activities in different enzymatic pathways in the body (e.g., neural, hormonal, muscle-related and blood clotting pathways). Thus, calcium supplementation can directly or indirectly affect important functions in the body, such as the control of blood pressure, plasma glucose, body weight, lipid profile and endothelial function. Since one publication reported increased cardiovascular risk due to calcium supplementation, many researchers have studied whether this risk actually exists; the results are conflicting, and the involved mechanisms are uncertain. However, studies that have evaluated the influence of the consumption of foods rich in calcium have reported no increase in the cardiovascular risk, which suggests that nutritional intake should be prioritized as a method for supplementation and that the use of calcium supplements should be reserved for patients who truly need supplementation and are unable to achieve the recommended daily nutritional intake of calcium.


Sujets)
Humains , Ostéoporose/prévention et contrôle , Os et tissu osseux/effets des médicaments et des substances chimiques , Calcium alimentaire/administration et posologie , Maladies cardiovasculaires/induit chimiquement , Compléments alimentaires/effets indésirables , Agents de maintien de la densité osseuse/administration et posologie , Vitamine D/usage thérapeutique , Calcium alimentaire/effets indésirables , Maladies cardiovasculaires/mortalité , Densité osseuse/effets des médicaments et des substances chimiques , Essais contrôlés randomisés comme sujet , Méta-analyse comme sujet , Calcium/usage thérapeutique , Facteurs de risque , Facteurs âges , Fractures osseuses/prévention et contrôle , Agents de maintien de la densité osseuse/effets indésirables , Apports nutritionnels recommandés
2.
Arq. bras. endocrinol. metab ; 58(5): 530-539, 07/2014. tab, graf
Article Dans Anglais | LILACS | ID: lil-719196

Résumé

Aging is associated with decreases in bone quality and in glomerular filtration. Consequently, osteoporosis and chronic kidney disease (CKD) are common comorbid conditions in the elderly, and often coexist. Biochemical abnormalities in the homeostasis of calcium and phosphorus begin early in CKD, leading to an increase in fracture risk and cardiovascular complications since early stages of the disease. The ability of DXA (dual energy X-ray absorptiometry) to diagnose osteoporosis and to predict fractures in this population remains unclear. The management of the disease is also controversial: calcium and vitamin D, although recommended, must be prescribed with caution, considering vascular calcification risk and the development of adynamic bone disease. Furthermore, safety and effectiveness of osteoporosis drugs are not established in patients with CKD. Thus, risks and benefits of antiosteoporosis treatment must be considered individually.


O envelhecimento associa-se tanto ao declínio da qualidade óssea quanto da filtração glomerular. Consequentemente, osteoporose e doença renal crônica (DRC) são comorbidades frequentes em idosos, e muitas vezes coexistem. Anormalidades bioquímicas na homeostase do cálcio e do fósforo surgem precocemente na DRC, causando aumento do risco de fraturas e de complicações cardiovasculares desde fases precoces da doença. A capacidade da densitometria (DXA) em diagnosticar osteoporose e predizer fraturas nessa população é questionável. O manejo da doença é também controverso; cálcio e vitamina D são recomendados com cautela, devido ao risco de calcificações vasculares e de doença óssea adinâmica. Além disso, a segurança e a eficácia dos medicamentos para osteoporose ainda não estão estabelecidas em pacientes com DRC. Assim, riscos e benefícios do tratamento para osteoporose devem ser considerados individualmente nesses pacientes.


Sujets)
Humains , Agents de maintien de la densité osseuse/usage thérapeutique , Maladies osseuses métaboliques/complications , Fractures osseuses/étiologie , Ostéoporose/complications , Ostéoporose/traitement médicamenteux , Insuffisance rénale chronique/complications , Densité osseuse , Agents de maintien de la densité osseuse/effets indésirables , Calcium alimentaire/usage thérapeutique , Débit de filtration glomérulaire , Hyperparathyroïdie secondaire/physiopathologie , Ostéoporose/prévention et contrôle , Insuffisance rénale chronique/métabolisme , Ostéodystrophie rénale/métabolisme
3.
Rev. Soc. Bras. Clín. Méd ; 6(2): 79-82, mar.-abr. 2008. ilus
Article Dans Portugais | LILACS | ID: lil-491529

Résumé

A encefalite herpética (EHS) é uma patologia grave, com alto índice de morbidade e letalidade. Esta doença se expressa por um quadro clínico agudo, tendo como principais manifestações:febre, cefaléia e alterações cognitivas e psíquicas. Desta forma, a suspeição clínica, associada a exames laboratoriaise de imagem são de fundamental importância para a detecção precoce e tratamento imediato desta patologia, a fim de impedir sua progressão rapidamente fatal. Neste relato, apresentamos um caso de EHS em uma paciente do sexo feminino, 48 anos, internada no Hospital dos Plantadores de Cana - Campos dos Goytacazes, RJ.(AU)


The herpes simplex encephalitis (HSE) is a serious pathology, with a high rate of morbidly and lethality. This diseasepresents a acute clinical condition, it had like principal symptons: fever, headache and cognitive and psychological alterations. In such a way, the clinical suspicion is associated to laboratorials examinations and of image. This are extremely important to early detect and fast treatment this pathology, on purpose to impede the quickly fatal progression of the illness. In this report, we present a case of Herpes Simplex Encephalitis in a forty-eight-years old female-patient, to taken into thePlantadores de Cana Hospital - Campos dos Goytacazes, RJ.(AU)


Sujets)
Humains , Femelle , Adulte d'âge moyen , Herpèsvirus humain de type 1 , Encéphalite à herpès simplex/diagnostic , Encéphalite à herpès simplex/traitement médicamenteux , Aphasie/étiologie , Crises épileptiques/étiologie , Aciclovir/usage thérapeutique , Réaction de polymérisation en chaîne/instrumentation , Fièvre/étiologie , Céphalée/étiologie , Nausée/étiologie
SÉLECTION CITATIONS
Détails de la recherche